Allianz Asset Management
CDLX icon

Allianz Asset Management’s Cardlytics CDLX Stock Holding History

Allianz Asset Management’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-6,027
Closed -$6.61M – 2398
2021
Q1 		$6.61M Sell
6,027
-5,911
-50% -$7.8M 0.01% 967
2020
Q4 		$17M Buy
11,938
+5,931
+99% +$6.33M 0.02% 671
2020
Q3 		$4.24M Sell
6,007
-3,643
-38% -$2.65M ﹤0.01% 1039
2020
Q2 		$6.75M Buy
9,650
+5,627
+140% +$3.25M 0.01% 1064
2020
Q1 		$1.41M Sell
4,023
-2,376
-37% -$1.68M ﹤0.01% 1655
2019
Q4 		$4.02M Sell
6,399
-241
-4% -$118K ﹤0.01% 1579
2019
Q3 		$2.23M Sell
6,640
-10,104
-60% -$3.24M ﹤0.01% 1788
2019
Q2 		$4.35M Sell
16,744
-3,971
-19% -$795K ﹤0.01% 1571
2019
Q1 		$3.43M Buy
20,715
+2,431
+13% +$395K ﹤0.01% 1625
2018
Q4 		$1.98M Buy
18,284
+1,184
+7% +$200K ﹤0.01% 1769
2018
Q3 		$4.28M Buy
+17,100
New +$3.68M ﹤0.01% 1633

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
ACM
Alua Capital Management New York $1.13B AUM 8.41% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $620M AUM 14.15% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AA
Antipodean Advisors New York $19.5M AUM 6.21% 1-Year Est. Return

Allianz Asset Management's CDLX Position: Q2 2021 in Review

Allianz Asset Management sold out of Cardlytics (CDLX) in Q2 2021, closing a stake of 6,027 shares — an estimated $6.61M sold.

Allianz Asset Management first reported a position in CDLX in Q3 2018 and held it in 11 quarters. The position peaked at $17M in Q4 2020. 189 funds tracked by Wall St. Rank hold CDLX as of Q2 2021.

  • Allianz Asset Management reported no remaining Cardlytics position as of Q2 2021 after selling out during the quarter.
  • Allianz Asset Management sold 6,027 Cardlytics shares in Q2 2021, an estimated $6.61M.
  • Allianz Asset Management first reported a position in Cardlytics in Q3 2018 and held it in 11 quarters.
  • Allianz Asset Management's Cardlytics position peaked at $17M in Q4 2020.
  • 189 funds tracked by Wall St. Rank held Cardlytics as of Q2 2021.

Based on Allianz Asset Management's 13F filing for Q2 2021, filed 16 Aug 2021.